BROADSTONE ACQUISITION COR-A (BSN) Stock Price, Quote, News and Overview
NYSE:BSN - New York Stock Exchange, Inc. - Common Stock
BSN Quote, Performance and Key Statistics
10.68
+1.71 (+19.06%)
The current stock price of BSN is 10.68 null. In the past month the price increased by 7.34%. In the past year, price increased by 7.23%.
About BSN
Company Profile
Broadstone Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The firm is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on businesses in the United Kingdom and Europe. The firm has not conducted any operations and has not generated any revenues.
Company Info
BROADSTONE ACQUISITION COR-A
7 Portman Mews South
London GB
Employees: 2
Phone: 4402077250800.0
BROADSTONE ACQUISITION COR-A / BSN FAQ
What is the stock price of BROADSTONE ACQUISITION COR-A today?
The current stock price of BSN is 10.68 null. The price increased by 19.06% in the last trading session.
What is the ticker symbol for BROADSTONE ACQUISITION COR-A stock?
The exchange symbol of BROADSTONE ACQUISITION COR-A is BSN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is BSN stock listed?
BSN stock is listed on the New York Stock Exchange, Inc. exchange.
What is BROADSTONE ACQUISITION COR-A worth?
BROADSTONE ACQUISITION COR-A (BSN) has a market capitalization of 407.58M null. This makes BSN a Small Cap stock.
How many employees does BROADSTONE ACQUISITION COR-A have?
BROADSTONE ACQUISITION COR-A (BSN) currently has 2 employees.
What are the support and resistance levels for BROADSTONE ACQUISITION COR-A (BSN) stock?
BROADSTONE ACQUISITION COR-A (BSN) has a support level at 10 and a resistance level at 10.69. Check the full technical report for a detailed analysis of BSN support and resistance levels.
Should I buy BROADSTONE ACQUISITION COR-A (BSN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BSN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BSN, evaluating the profitability, health, valuation and growth aspects
- BROADSTONE ACQUISITION COR-A (BSN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BROADSTONE ACQUISITION COR-A (BSN) Sales and EPS estimates to see what analysts future expectations are.
- BROADSTONE ACQUISITION COR-A (BSN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BROADSTONE ACQUISITION COR-A (BSN) Insider and Institutional Ownership to learn about the owners and their transactions.
- BROADSTONE ACQUISITION COR-A (BSN) Stock Chart to make your own analysis
- BROADSTONE ACQUISITION COR-A (BSN) Latest news and press-releases to stay up to date.
Does BROADSTONE ACQUISITION COR-A (BSN) stock pay dividends?
BSN does not pay a dividend.
What is the Price/Earnings (PE) ratio of BROADSTONE ACQUISITION COR-A (BSN)?
BROADSTONE ACQUISITION COR-A (BSN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
BSN Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BSN. When comparing the yearly performance of all stocks, BSN turns out to be only a medium performer in the overall market: it outperformed 59.63% of all stocks.
BSN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BSN. Both the profitability and financial health of BSN have multiple concerns.
BSN Financial Highlights
Over the last trailing twelve months BSN reported a non-GAAP Earnings per Share(EPS) of -0.07.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.94% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |